HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

AQ4N

structure given in first source
Also Known As:
1,4-bis-((2-(dimethylamino)ethyl)amino)-5,8-dihydroxyanthracene-9,10-dione; 1,4-bis-((2-(dimethylamino-N-oxide)ethyl)amino)-5,8-dihydroxyanthracene-9,10-dione
Networked: 25 relevant articles (3 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Patterson, L H: 5 articles (06/2007 - 04/2000)
2. Lalani, Alshad S: 4 articles (02/2009 - 04/2007)
3. McKeown, Stephanie R: 3 articles (03/2013 - 01/2003)
4. Albertella, Mark R: 3 articles (12/2009 - 04/2007)
5. Wong, Alvin: 3 articles (11/2008 - 04/2007)
6. McKeown, S R: 3 articles (06/2006 - 04/2000)
7. Williams, Kaye J: 2 articles (08/2015 - 12/2009)
8. Telfer, Brian A: 2 articles (08/2015 - 12/2009)
9. Ward, Claire: 2 articles (03/2013 - 03/2008)
10. Worthington, Jenny: 2 articles (03/2013 - 03/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Anoxia (Hypoxia)
4. Fibrosarcoma
5. Gliosarcoma

Related Drugs and Biologics

1. Mitoxantrone (Novantrone)
2. Type II DNA Topoisomerases (Topoisomerase II)
3. Prodrugs
4. Cytochrome P-450 Enzyme System (Cytochrome P450)
5. Cytochrome P-450 CYP3A
6. Protein Isoforms (Isoforms)
7. Topotecan (Hycamtin)
8. Cytochrome P-450 CYP1A1 (CYP1A1)
9. NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)
10. Cytokines

Related Therapies and Procedures

1. Radiotherapy
2. Heterologous Transplantation (Xenotransplantation)
3. Drug Therapy (Chemotherapy)